Drug Abuse Methadone: Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
Drug Abuse Methadone: Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
Cephalon, Inc. announced today that the U.S. Food and Drug Administration approved the Risk Evaluation and Mitigation Strategy for FENTORA® [C-II ] and ACTIQ® [C-II ].  Both products are indicated for the management of breakthrough pain in opioid-tolerant patients with cancer.  Under this REMS, pharmacies and healthcare professionals who prescribe FENTORA and ACTIQ will enroll by completing …
Drug Abuse Methadone – Yahoo! News Search Results
Find More Drug Abuse Methadone Information…